Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

NCT04979884 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Acute Respiratory Distress Syndrome
Cytokine Release Syndrome
Pulmonary Fibrosis

Interventions

DRUG: cyclosporine

Sponsor

Alexandria University

Collaborators

[object Object]